Table 2.
The relationship between I stage and clinicopathological characteristics.
| I stage 0 | I stage 1 | I stage 2 | I stage 3 | P value | |
|---|---|---|---|---|---|
| (n = 112) | (n = 97) | (n = 66) | (n = 48) | ||
| Age (years) | 0.817 | ||||
| ≤60 | 66 | 58 | 37 | 25 | |
| >60 | 46 | 39 | 29 | 23 | |
| Gender | 0.375 | ||||
| Female | 18 | 14 | 5 | 5 | |
| Male | 94 | 83 | 61 | 43 | |
| Tumor length (cm) | <0.001 | ||||
| ≤3 | 45 | 31 | 9 | 4 | |
| >3 | 67 | 66 | 57 | 44 | |
| Tumor location | 0.488 | ||||
| Upper | 8 | 4 | 1 | 4 | |
| Middle | 51 | 49 | 28 | 23 | |
| Lower | 53 | 44 | 37 | 21 | |
| Vessel involvement | 0.385 | ||||
| Negative | 99 | 79 | 54 | 38 | |
| Positive | 13 | 18 | 12 | 10 | |
| Perineural invasion | 0.043 | ||||
| Negative | 98 | 70 | 52 | 40 | |
| Positive | 14 | 27 | 14 | 8 | |
| Differentiation | 0.310 | ||||
| Good | 17 | 10 | 12 | 5 | |
| Moderate | 80 | 65 | 41 | 30 | |
| Poor | 15 | 22 | 13 | 13 | |
| T stage | <0.001 | ||||
| T1 | 33 | 18 | 3 | 1 | |
| T2 | 23 | 14 | 11 | 7 | |
| T3 | 50 | 58 | 42 | 29 | |
| T4 | 6 | 7 | 10 | 11 | |
| N stage | <0.001 | ||||
| N0 | 71 | 55 | 32 | 16 | |
| N1 | 30 | 30 | 12 | 15 | |
| N2 | 6 | 9 | 12 | 10 | |
| N3 | 5 | 3 | 10 | 7 | |
| TNM stage | <0.001 | ||||
| I | 46 | 21 | 9 | 5 | |
| II | 31 | 41 | 22 | 10 | |
| III | 35 | 35 | 35 | 33 |